Renal toxicity of anticancer agents targeting HER2 and EGFR

Journal of Nephrology
Laura CosmaiCamillo Porta

Abstract

EGFR and HER2 are found overexpressed and/or activated in many different human malignancies (e.g. breast and colon cancer), and a number of drugs specifically targeting these two tyrosine kinases have been developed over the years as anticancer agents. In the present review, the renal safety profile of presently available agents targeting either HER2 or EGFR will be discussed, together with the peculiarities related to their clinical use in patients with impaired renal function, or even in dialysis. Indeed, even though renal toxicity is not so common with these agents, it may nevertheless happen, especially when these agents are combined with traditional chemotherapeutic agents. As a whole, kidney impairment or dialysis should not be regarded per se as reasons not to administer or to stop an active anti-HER or anti-EGFR anticancer treatment, especially given the possibility of significantly improving the life expectancy of many cancer patients with the use of these agents.

References

Oct 1, 1996·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C CarlomagnoS De Placido
May 31, 2002·Expert Opinion on Investigational Drugs·Fortunato Ciardiello, Giampaolo Tortora
Oct 25, 2003·The Journal of Biological Chemistry·Thomas VoetsJoost G J Hoenderop
Jun 16, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ryuichiro KumasakaKen Okumura
Jul 23, 2004·The New England Journal of Medicine·David CunninghamEric Van Cutsem
Feb 17, 2005·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Antonio RossiCesare Gridelli
Jul 15, 2005·The New England Journal of Medicine·Frances A ShepherdUNKNOWN National Cancer Institute of Canada Clinical Trials Group
Aug 18, 2005·Journal of the National Cancer Institute·Deborah SchragLeonard Saltz
Oct 21, 2005·The New England Journal of Medicine·Harold J Burstein
Feb 10, 2006·The New England Journal of Medicine·James A BonnerK Kian Ang
May 19, 2006·The New England Journal of Medicine·Kathleen I PritchardUNKNOWN National Cancer Institute of Canada Clinical Trials Group
Sep 2, 2006·Clinical Colorectal Cancer·Marwan G FakihJeffrey Lombardo
Sep 29, 2006·Lung·Hsiang-Lin Wan, Nai-Shun Yao
Dec 29, 2006·The New England Journal of Medicine·Charles E GeyerDavid Cameron
Apr 25, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Malcolm J MooreUNKNOWN National Cancer Institute of Canada Clinical Trials Group
May 2, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Eric Van CutsemRafael G Amado
Jun 15, 2007·Clinical Oncology : a Journal of the Royal College of Radiologists·R A MicallefL Williams
Aug 3, 2007·The Journal of Clinical Investigation·Wouter M Tiel GroenestegeRené J Bindels
Nov 16, 2007·The New England Journal of Medicine·Derek J JonkerMalcolm J Moore
Feb 29, 2008·Journal of Anesthesia·Kohki NishikawaAkiyoshi Namiki
Apr 9, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Alberto F SobreroHoward A Burris
Sep 12, 2008·The New England Journal of Medicine·Jan B VermorkenRicardo Hitt
Mar 14, 2009·Head & Neck·Ibrahim T AldossApar Kishor Ganti
Apr 3, 2009·The New England Journal of Medicine·Eric Van CutsemPhilippe Rougier
May 1, 2009·Critical Reviews in Oncology/hematology·Hassane IzzedineJean Charles Soria
Aug 21, 2009·The New England Journal of Medicine·Tony S MokMasahiro Fukuoka
Aug 21, 2009·The New England Journal of Medicine·Rafael RosellUNKNOWN Spanish Lung Cancer Group
Sep 18, 2009·Cancer Chemotherapy and Pharmacology·Yunfei CaoFeng Gao
Sep 30, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Stephen JohnstonMark Pegram
Feb 4, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Kimberly L BlackwellJoyce O'Shaughnessy
Mar 18, 2010·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Yosuke TogashiMichiaki Mishima
May 27, 2010·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Yosuke TogashiKen-ichi Inui
Jul 3, 2010·Journal of the American Society of Nephrology : JASN·Henrik DimkeRené J Bindels
Oct 6, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Marc PeetersJennifer Gansert

❮ Previous
Next ❯

Citations

Mar 25, 2017·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Hassan Izzedine, Mark A Perazella
Nov 16, 2019·Journal of Clinical Pharmacy and Therapeutics·Xiaodong LiuLi Zhao
Oct 6, 2017·American Journal of Physiology. Renal Physiology·Kevin D WrightAndrey Sorokin
Apr 19, 2019·International Journal of Molecular Sciences·Zhi-Guo ZouRhian M Touyz
Jul 19, 2017·Journal of Enzyme Inhibition and Medicinal Chemistry·You-Guang ZhengMin Ji
Jun 21, 2018·Current Treatment Options in Cardiovascular Medicine·Isaac B Rhea, Guilherme H Oliveira
Mar 30, 2021·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·Kelly M GaertnerChristie Hilton

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Frontiers in Bioscience (Elite Edition)
Giuseppe BronteAntonio Russo
Nihon rinsho. Japanese journal of clinical medicine
Kiyohiko Hatake
Transactions of the Association of Life Insurance Medical Directors of America
J P Kassirer
© 2021 Meta ULC. All rights reserved